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Purpose.The incidence ofliver tumors is risingin USA.The purposeof this studywas to evaluate liver oxido-reductive status inthe
presence of chronic liver disease and hepatocellular carcinoma (HCC). Methods. Glutathione species and ophthalmate (OA) con-
centrationsweremeasuredbyLC-MSinprocessedplasmaandredbloodcells(RBC)frominfectedWoodchuckwithhepatitisvirus
(WHV). Blood samples were obtained from: (i) infected animals with tumors (WHV+/HCC+), (ii) infected animals without
tumors (WHV+/HCC−) and (iii) healthy animals (WHC−/HCC−). Results. The concentration of reduced glutathione (GSH)
andtheratioGSH/GSGwerelowerinplasmafromWHV+/HCC+animalswhencomparedtoWHV+/HCC−andWHV−/HCC−
(P<0.01). In contrast, the concentration of oxidized glutathione (GSSG) was found to be higher in plasma from WHV+/HCC+
animals when compared to WHV+/HCC− and WHV−/HCC− (P<0.01). The Glutathione species and its ratio from the RBC
compartment were similar among all groups. OA concentration in both plasma and RBC was signiﬁcantly higher from WHV+/
HCC+ when compared to WHV+/HCC− and WHV−/HCC− (P<0.01). Conclusions. Disturbances of the glutathione redox
buﬀer system and higher concentrations of OA were found in the WCV+/HCC+ animal model. The role of these compounds as
biomarkers of early tumor development in patients with end stage liver disease remains to be determined.
1.Introduction
Hepatocellular carcinoma (HCC) is the fourth most com-
mon cancer in the world, with a high lethality index [1]. It
develops and ﬂourishes mostly in patients with liver disease,
and its incidence is on the rise in United States due to an
increase in hepatitis C virus (HCV) infection and nonalco-
holic steatohepatitis (NASH) [1]. 80% of these tumors are
surgically untreated at the time of diagnosis because of an
advanced stage or due to a medical condition that prohibits
resectionortransplantation,theonlycurativetreatments[2].
Screeningprogramsinhigh-riskpopulations including serial
α-fetoprotein measurements and liver ultrasonography had
failedtheiraimtowardsearlytumordetection[3–5].Authors
have postulated metabolic substrates as a form of biomarker
for the early detection of liver cancer [6].2 HPB Surgery
The reduced glutathione:oxidized glutathione (GSH:
GSSG) couple is the most important intracellular buﬀer sys-
tem against oxidative stress [7, 8] .P e r t u r b a t i o n so ft h i ss y s -
tem and other oxidative stress changes have been previously
reported in relation to diﬀerent cancers [7–9]. Soga et al.
in 2006 showed that serum levels of ophthalmate (OA), an
analogofglutathione,canbeusedasanindexofintracellular
GSH depletion/oxidative stress [10]. We have shown that
disturbances of the glutathione redox buﬀer system and OA
were present in the VX2 rabbit model of secondary liver
tumorsasearlyas14daysaftertumorimplantationandthese
changes were caused by an oxidative stress reaction within
the tumor surroundings in response to the neoplastic growth
[11].Inthepresentwork,wehypothesizedthatthesechanges
can also be detected in animals with chronic viral hepatitis-
induced HCC and that complete ablation of the tumors will
not altered the disturbances of the glutathione/OA buﬀer
system observed in early tumor development, since these are
produced in the surrounding healthy liver tissues in reaction
to a growing mass in need for energy substrates. To answer
thisquestionwemadeuseofthewell-establishedwoodchuck
hepatitis virus- (WHV-) induced HCC model [12, 13].
Summers et al. in 1978 reported a high incidence of HCC
(23%) arising in a background of chronic active hepatitis in
a colony of captive woodchucks studied for 18 years [14].
Gerin et al. in 1989 described that almost 97% of chronic
WHVcarriersdevelopedHCCwithin3yearsofWHVexper-
imental inoculation [15]. We found a signiﬁcant decrease in
the GSH/GSSG ratio and an increase in the concentrations
of OA in plasma from infected animals with tumors when
compared to both infected animals without tumors and
healthy controls (noninfected animals without tumors).
2.MaterialsandMethods
2.1. Animal Model. Woodchucks (marmota monax), 21–36
months old, weighing 2.5–2.75kg (Northeastern Wildlife
Inc., Harrison, Idaho, USA) were quarantined for 15 days
and maintained in ﬁxed conditions of day-light cycle and
humidity with access to water and food (Teklad, Madison,
Wis, USA) ad libitum. They were fasted overnight before any
procedure. All animal protocols were approved by the Insti-
tutional Animal Care and Use Committee (IACUC) at Case
Western Reserve University and conducted in accordance
to their guidelines. Animal groups consisted of: (i) healthy
woodchucks(noninfectedwithouttumors=WHV−/HCC−,
n = 4), (ii) chronic WHV-infected woodchucks without
tumors (WHV+/HCC−, n = 4), and (iii) experimental
animals (WHV-infected with tumors = WHV+/HCC+, n =
4−1).Onemaleanimalfromtheexperimentalgroupbecame
ill during the quarantine period and was excluded from the
protocol.
2.2. Tumor Ablation. WHV+/HCC+ animals were anes-
thetized with intramuscular (IM) Xylazine (5mg/kg) and
Ketamine (50mg/kg). IV ﬂuids were administered through a
sublingualveincatheterandtheirabdominalwallwasshaved
and swabbed with povidone-iodine solution (Betadine,
Mich, USA) prior to a midline laparotomy. Livers were
inspected and tumors were ablated with a Valleylab Cool-
tip RF ablation system (Valleylab/Tyco Healthcare Group,
Boulder, Colo, USA) for 12 minutes under continuous
impedance. Ablation electrodes included a 0.7cm probe for
a 1.5cm ablation area and a 1cm probe for a 2cm ablation
area. The size of the ablation electrode was selected in a
case-by-case basis according to the tumor size. A total of 2
to 3 ablations were performed per animal with the goal of
complete tumor ablation.
2.3. Blood Sampling. Baseline blood samples were collected
from all groups in a heparinized tube before any proce-
dure and repeated 8 hours after tumor ablation in the
experimentalgroup.Sampleswereimmediatelycooleddown
in iced water. After centrifugation at 3,000rpm at 4◦C
for 10min, the plasma and red blood cells (RBCs) were
separated in cryogenic vials for GSH/GSSG/OA assay. To
prevent its oxidation, GSH was immediately converted to a
stable carboxymethyl thioether by treating 500μL of plasma
with 500μL of 50mM iodoacetate in 10mM ammonium
bicarbonate, pH = 10, adjusted with concentrated ammonia.
After removal of the plasma, 50μL of the RBC pellet was
transferredtoacryogenicvialandtreatedwith450μLo fIAA
buﬀer [16]. Snap-frozen aliquots of plasma and RBC were
stored at −80◦C until analysis.
2.4. Imaging Procedures. In order to demonstrate the pres-
ence of liver tumors, we obtained positron emission tomog-
raphy (PET) scans 1 week before surgery with three dif-
ferent tracers: (i) 2-deoxy-2[18F]-ﬂuoro-D-glucose (FDG),
(ii) [1-11C]-acetate (acetate), and (iii) [N-methyl-11C]-
choline (choline). Tracers were synthesized in our lab [17].
Two postoperative PET scans were performed at 4 and 7
hours after tumor ablation with acetate (15 minutes after
giving the radioisotope) and FDG (1 hour after giving the
radioisotope), respectively. The Allegro PET scanner (Philips
Medical Systems Inc., Cleveland, Ohio) was used with three-
dimensional acquisition. Images were reconstructed using
ﬁltered backprojection with attenuation correction using the
transmission scan [17].
2.5.PathologicAnalysis. EighthoursafterRFAofthetumors,
woodchucks were euthanized and their livers removed.
Liver were perfused-ﬁxed with 10% formaldehyde and 90%
phosphate-buﬀered saline at room temperature. Liver tissue
was embedded in paraﬃn blocks to be cut and then Hema-
toxylin and Eosin stained. Blinded slides were assessed by
two pathologists specialized in liver disease. Digital records
fromtumorswereusedtodeterminetheirsize(Digi3Digital
Binocular Microscope and software, LaboMed, Calif, USA).
2.6. GSH/GSSG/OA Assay. Plasma and RBC concentrations
of glutathione species GSH:GSSG and OA were measured
using LC-MS/MS methods validated in our laboratory
[16]. In brief, the protected plasma samples were spiked
with homoglutathione as internal standard (Chem-Impex
International Inc., Wood Dale, Ill, USA). For the RBCHPB Surgery 3
(a) Pre-ablation (RFA) (b) Post-ablation (RFA)
Figure 1: Radioactive tracer uptake of livers from WHV-induced HCC woodchuck model using 18F-glucose (FDG), 11C-acetate and 11C-
choline. (a) Representative imaging of an animal with WHV-induced HCC in which the uptake of FDG was negative while the uptake of
11C-acetate and 11C-choline were positive. (b) After radiofrequency ablation (RFA) of the tumor the uptake of FDG and 11C-acetate were
lower than the surrounding liver tissue.
samples,10μLoftheprotectedsamplewasdilutedin90μLof
waterandspikedwiththesameamountofhomoglutathione.
Iodoacetate treated samples were kept in the dark at room
temperature for 45min to allow completion of the reaction.
To liberate the bound glutathione, 200μL of DTT (100mM,
pH 10, in 10mM ammonium bicarbonate) was added and
allowed to react in the dark for 15min at room temperature.
To this solution, 200μL of iodoacetonitrile (200mM, pH
10, in 10mM ammonium bicarbonate containing 3.12μM
homoglutathione (623pmol/200μL)) was added to convert
the liberated glutathione to a cyanomethyl-thioether. After
30min standing at room temperature in the dark, 1.5mL
of acetonitrile was added to precipitate the proteins. After
completing all reactions, sample was dried at 50◦Cu n d e r
air at 20psi for 40min and reconstituted in formic acid
in water (0.1% vol:vol). This was injected into a liquid
chromatograph (Agilent 1100, Agilent Technologies Inc.,
Palo Alto, CA) equipped with an API 4000 QTrap mass
spectrometer (Applied Biosystems, Foster City, CA) operated
under positive ionization mode. A Hypersil Gold C18
column (2.1 × 150mm, 5μmp a r t i c l es i z e ;T h e r m oE l e c t r o n
Corp.) was used at room temperature. Mobile phase A was
0.15% formic acid in water-acetonitrile (99:1, vol:vol),
and mobile phase B was 0.15% formic acid in water-
acetonitrile (5:95 vol:vol). Using a gradient elution, the
compounds were eluted at a ﬂow rate of 0.2mL/min.
Analyst software (version 1.4.1; Applied Biosystems, Foster
City, Calif) was used for data registration and analysis.
The MRM ion pairs monitored (precursor → product)
were (i) for carboxymethyl-GSH: 366.1 → 237.2, (ii) for
cyanomethyl-GSH derived from GSSR: 347.2 → 272.1, (iii)
for carboxymethyl-homoglutathione: 380.1 → 233.1, (iv)
for cyanomethyl-homoglutathione: 361.1 → 232.1, and (v)
for ophthalmate: 290.3 → 161.1. The GSH/GSSG ratio was
calculated using the formula (GSH)/(GSSG/2).
2.7. Statistical Analysis. Mean values ± standard deviations
are presented (M ± SD). One-sided paired t-tests were used
to calculate signiﬁcance of diﬀerence in the mean values
from same animals before and after tumor ablation. One-
sided independent t-tests were used to calculate signiﬁcance
of diﬀerence in the mean values between the experimental
group and other groups. A P value <0.05 was considered
statistically signiﬁcant.
3. Results
PET scans 1 week before tumor ablation showed that the
uptake of FDG in all tumor bearing woodchucks 1 hour
afterisotope injection wassimilar tothesurrounding hepatic
tissues (tumor-to-liver ratio ≤1.15, Figure 1(a),F D G ) .I n
contrast, when using acetate and choline as radiotracers
a focal uptake in HCC was evident (Figure 1(a),a c e t a t e
and choline). Scans after tumor ablation showed a lower
uptake of FDG and acetate than the surrounding hepatic
tissues in all ablated areas, and no hypermetabolic focus
was seen (Figure 1 (b)). No signs of metastasis were noted
at imaging or during surgery. Liver tumor masses were
evident in all experimental animals during surgery. The
mean diameter of tumors was 4.35 ± 1.75mm. Histologic
examination showed mild-to-moderate chronic hepatitis,
mild-to-moderate steatosis and mild portal ﬁbrosis pro-
gressing to bridging ﬁbrosis. Conclusive malignancies were
present in two experimental animals while controversy was
present between pathologists for the third animal: HCC
versus highly dysplastic nodules (Figure 2). Animals in other
groups showed no evidence of malignancy.
Plasma concentration of GSH was signiﬁcantly lower in
the WHV+/HCC+ group when compared to WHV+/HCC−
and to WHV−/HCC− groups (7.23 ± 0.95 versus 20.50 ±
1.90 versus 14.44 ± 1.25μM, P = 0.0002, Figure 3). In4 HPB Surgery
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Figure 2: Light microscopy of liver tissue from WHV-infected woodchucks. (a) Liver tissue is shown with areas of mild chronic hepatitis,
steatosis, and mild portal ﬁbrosis, characteristic of mild WHV infection (H&E, 100x), while other areas showed portal triad ﬁbrosis with
severe steatosis (b) progressing to bridging ﬁbrosis (c). (d) A region of severe dysplasia versus HCC (H&E, 200x). (e) HCC with minimal
steatosis containing mononuclear cells. (f) Liver tissue containing malignancy after complete tumor ablation (H&E, 100x) and a 2mm
margin around ablated area showing cell apoptosis (g), (TUNEL assay, 100x).
contrast, the concentration of GSSG was signiﬁcantly higher
in the WHV+/HCC+ when compared to WHV+/HCC−
and to WHV−/HCC− (4.45 ± 0.13 versus 1.25 ± 0.17 and
0.83 ± 0.25μM, P = 0.003, Figure 3). The GSH/GSSG ratio
was 12.1 to 13.4 times lower in the WHV+/HCC+
animals when compared to the WHV+/HCC− and to
WHV−/HCC− groups, respectively (2.71 ± 0.68 versus
33.06 ± 1.72 and 36.38 ± 7.55, P = 0.0003, Figure 3).
The plasma concentration of ophthalmate was increased 4.5-
fold in the WHV+/HCC+ group when compared to the
WHV+/HCC− animals and 22-fold when compared to the
WHV−/HCC− (0.91 ± 0.24 versus 0.20 ± 0.14 and 0.04 ±
0.01μM, P = 0.002, Figure 4). Concentrations of GSH from
the WHV+/HCC+ woodchucks increased signiﬁcantly 8
hours after tumor ablation when compared to their baseline
levels (7.2 ± 0.9 → 10.3 ± 2.5μM, P = 0.048, paired t-test,
Figure 3). The changes in concentration of GSSG, OA and
the GSH/GSSG ratio before and after tumor ablation were
not statistically signiﬁcant (P>0.05, paired t-test).
RBCs GSH concentration was signiﬁcantly higher in the
WHV+/HCC+ group when compared to WHV+/HCC−
group (87.48 ± 14.02 versus 67.93 ± 6.64μM, P = 0.027,
Figure 5) and similar to the WHV−/HCC− group (80.30
± 15.11μM, P = 0.274, Figure 5). RBCs GSSG concentra-
tion was similar in WHV+/HCC+ when compared to
WHV+/HCC− and to WHV−/HCC− (16.06 ± 4.61 versus
6.61 ± 2.67 and 5.81 ± 2.01μM, P>0.05, Figure 5).
The GSH/GSSG ratio was similar among groups (P>0.05,HPB Surgery 5
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Figure 3: Concentration of glutathione species and their ratio
in plasma from the WHV-induced HCC woodchuck model
(μM). The reduced form (GSH), the oxidized form (GSSG) of
glutathione and their ratio were measured in processed plasma
samples of healthy woodchucks (WHV−/HCC−), WHV-infected
woodchucks (WHV+/HCC−), and WHV-induced HCC animals
(WHV+/HCC+, before and 8 hours after tumor ablation). Levels
of GSH were lower in the WHV+/HCC+ group when compared
to the WHV−/HCC− and WHV+/HCC− groups. In contrast,
levels of GSSG were higher in WHV+/HCC+ when compared to
WHV−/HCC− and WHV+/HCC−. The GSH/GSSG ratio pre-
sented a ∼12-fold decrease in plasma from WHV+/HCC+ animals
when compared to controls. Levels of GSH increased signiﬁcantly
after tumor ablation in the WHV+/HCC+ animals. ∗P<0.05, one-
sided independent t-test; †P<0.05, one-sided paired t-test.
Figure 5). In contrast, RBCs OA concentration was sig-
niﬁcantly higher in WHV+/HCC+ animals when com-
pared to WHV+/HCC− and WHV−/HCC− (10.06 ± 4.04
versus 0.81 ± 0.29 and 0.42 ± 0.17μM, P = 0.002,
Figure 6). Moreover, the RBCs GSH concentration sig-
niﬁcantly increased in the WHV+/HCC+ group after
tumor ablation when compared to preablation levels
(87.48 ±14.02 → 94.50 ±15.36μM,P = 0.048,pairedt-test,
Figure 5). The RBCs concentrations of GSSG, OA and the
GSH/GSSG ratio remained unchanged after tumor ablation
when compared to baseline levels prior ablation (P>0.05).
4. Discussion
Cell transformation to the one with a malignant and
uncontrolledgrowthisassociatedwithoxidativestress[7–9].
Previous studies in our lab have shown disturbances of the
glutathione redox buﬀer system and ophthalmate elevation
in the VX2 rabbit model of secondary liver tumors [11].
We hypothesized that these ﬁndings will also be present in
animals with viral hepatitis-induced HCC. Our data show a
signiﬁcant decrease in the plasma concentration of reduced
glutathione and GSH/GSSG ratio in animals with WHV-
induced HCC when compared to WHV-infected animals
without tumors and healthy controls. In addition, oxidized
glutathione and ophthalmate concentrations were found to
be signiﬁcantly higher in the WHV-induced HCC animals
when compared to the other groups. These ﬁndings indicate
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Figure 4: Concentration of ophthalmate (OA) in plasma from the
WHV-induced HCC woodchuck model (μM). The concentrations
of OA were measured in plasma samples of healthy woodchucks
(WHV−/HCC−), WHV-infected woodchucks (WHV+/HCC−)
and WHV-induced HCC animals (WHV+/HCC+, before and 8
hours after tumor ablation). Levels of OA were signiﬁcantly higher
in the WHV+/HCC+ when compared to WHV+/HCC− and
WHV−/HCC−. OA levels were also higher in WHV+/HCC− when
comparedwiththeWHV−/HCC−.Levels ofOAweresimilarinthe
WHV+/HCC+ before and after tumor ablation. ∗P<0.05, one-
sided independent t-test.
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Figure 5: Concentration of glutathione species and their ratio in
RBC samples from the WHV-induced HCC woodchuck model
(μM). The reduced form (GSH), the oxidized form (GSSG) of
glutathione and their ratio were measured in processed RBC
samples of healthy woodchucks (WHV−/HCC−), WHV-infected
woodchucks (WHV+/HCC−), and WHV-induced HCC animals
(WHV+/HCC+, before and 8 hours after tumor ablation). Levels
of GSH were higher in WHV+/HCC+ animals when compared to
WHV+/HCC− and it increased signiﬁcantly after tumor ablation.
GSH/GSSG ratio was similar among all groups. ∗P<0.05, one-
sided independent t-test; †P<0.05, one-sided paired t-test.
that a higher state of oxidative stress was present in this
animal model of HCC and can be potentially used as a
biomarker for early HCC detection in patients with chronic
liver disease.
Patients with advanced malignancies are usually in a
catabolic state. Authors have shown that high circulating
levels of tumor necrosis factor α (TNFα) and other cytokines
associated with tumor growth promoted low energy intake,
increased energy expenditure and negative energy balance
[18]. Mantovani et al. found a signiﬁcant increase in the6 HPB Surgery
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Figure 6: Concentration of ophthalmate (OA) in RBC samples
from the WHV-induced HCC woodchuck model (μM). The
concentrations of OA were measured in RBC samples of healthy
woodchucks (WHV−/HCC−), WHV-infected wood-chucks
(WHV+/HCC−), and WHV-induced HCC animals (WHV+/
HCC+, before and 8 hours after tumor ablation). The level of OA
was higher in WHV+/HCC+ when compared to WHV+/HCC−
and WHV−/HCC−. OA level was also higher in WHV+/HCC−
when compared with the WHV−/HCC−. Levels of OA were similar
in the WHV+/HCC+ group before and after tumor ablation.
∗P<0.05, one-sided independent t-test.
circulating levels of TNFα and IL-6 along with a reduced
activity of the enzyme glutathione peroxidase in patients
with advanced stage tumors (stage III-IV) [19]. Decreased
glutathione peroxidase activity is considered a surrogate
marker for oxidative stress, this is likely due to a decrease
availability of its substrate, reduced glutathione [18, 19].
In addition, the concentration of reduced glutathione in
plasma was found to be signiﬁcantly lower in patients with
advanced stages of lung, breast, colon, and renal cancer
[7–9]. We have shown for the ﬁrst time a signiﬁcant decrease
in the plasma concentrations of GSH in woodchucks with
HCC and chronic viral hepatitis when compared to animals
with hepatitis but without tumors or to healthy animals.
The glutathione redox couple is one of the main cellular
defensesagainstoxidativestress[7–10].F ailur eofthissyst em
may result in mitochondrial failure and apoptosis of healthy
cells enhancing a favorable microenvironment for further
malignant growth. Reduced glutathione (GSH) protects the
cell against reactive oxygen species (ROS) by becoming
oxidized to GS·, with further formation of glutathione
disulﬁde (GSSG) by combination of 2GS· radicals [20].
Therefore, GSSG is accumulated during oxidative stress,
and it can be reduced to GSH via glutathione reductase
or preferentially excreted to the plasma [21]. ROS are
involvedintheetiologyofcancerviaDNA-oxidativedamage,
inducing alterations of transcription factors such as p53
[22], nuclear factor kappa B and activator protein 1 [23]. In
addition, glutathione disturbances in cancer cells may play a
role in the development of metastatic potential and chemo-
resistance. Carretero et al. showed an increase concentration
of reduced glutathione during in vitro growth of a B16
melanoma cell line. Furthermore, intrasplenic inoculation of
high GSH concentration cells in mice showed a signiﬁcantly
high incidence of liver metastasis than low-GSH cells 10 days
after injection [24]. Cancer cells with a higher GSH content
are more resistant to chemotherapy and radiation therapy,
since they are more resistant to oxidative stress [21].
The tripeptide glutathione (γ-L-Glutamyl-L-cysteinyl-
glycine) is primarily synthesized in the liver, where it reaches
concentrations of ∼10mM, from where it is exported to
other organs [21, 25, 26]. The labeling proﬁle of plasma
glutathionespeciesissimilartotheliver:2%–3%perminute.
Since there is no synthesis of glutathione in plasma, the
labeling of plasma GSH:GSSG reﬂects the hepatic synthesis
of glutathione. Therefore, alterations in the liver glutathione
system can be directly measured in the plasma compartment
[16]. The role of the glutathione redox buﬀer system in
erythrocytes has been extensively studied. GSH synthesized
in the RBC protects the cell against oxygen radicals and it
is essential to maintain the integrity of the cell membrane.
The concentration of RBCs glutathione species is ∼10 times
higher than plasma. Kombu et al. showed that the RBCs
glutathione species labeling pattern is ∼7 times slower than
liver, which indicates a slow rate of synthesis and/or a slow
rate of import from the plasma compartment relative to the
larger RBCs pool size [16]. For this reason, their concentra-
tions do not reﬂect the status of the liver glutathione system.
Therefore, when using blood samples for glutathione species
measurement with the purpose of investigating liver distur-
bances, samples should be handled and processed carefully
(i.e., avoiding hemolysis) so that their concentrations truly
reﬂects the concentration of the liver-plasma compartment.
Glutathione species, their ratio and the concentration of OA,
was found to be signiﬁcantly higher in the plasma com-
partment of animals virus infected and with tumors when
compared to animals virus infected without tumors and to
healthy controls. In contrast, glutathione ratio was found to
be similar in the RBCs compartment in all animals groups.
Furthermore, the reduced fraction of glutathione increased
8 hours after tumor ablation in plasma of WHV+/HCC+
animals in both plasma and RBCs compartments, perhaps
representing, at least in part, an increased synthesis of
reduced glutathione by liver cells after a thermal injury with
subsequent release and increased plasma concentration and
perhaps percolation into circulating RBCs.
Ophthalmate is a nonthiol analog of glutathione. It is
produced under low cysteine conditions by the same
enzymes of glutathione synthesis, using L-2-aminobutyrate,
which contains an unreactive methyl group (–CH3), instead
of a thiol group (–SH). Since ophthalmate lacks a thiol
group, it cannot participate in the redox (thiol-mediated)
reactionsofGSH[10].Theconcentrationofliverglutathione
is the highest in the body, but the liver pool of ophthalmate
represents 1% of the size of the glutathione pool, since this
compound is excreted to the plasma [10]. Soga et al. recently
reported an increase in the concentrations of ophthalmate in
mice liver and plasma after induction of oxidative stress [10].
WefoundasigniﬁcantincreaseinplasmaandRBCsophthal-
mate concentration in animals with chronic hepatitis virus-
inducedHCCwhencomparedwithinfectedanimalswithout
tumors and healthy controls. The function of ophthalmate
is still under investigation; Leslie et al. in 2001 showed
that ophthalmate could support the uptake of [3H]NNAL-
O-glucuronide by multidrug resistance protein 1 (MRP1)HPB Surgery 7
at levels that were 60% of the GSH-mediated cotransport
mechanism, showing that the interaction GSH-MRP1 is not
entirely mediated by the thiol group [27]. Ophthalmate
was also found to competitively inhibit the canalicular liver
plasma membrane GSH transport system [28], resulting
in decrease GSH eﬄux from liver cells during oxidative
stress [10]. Since ophthalmate production increase in a state
of GSH depletion/oxidative stress, the previously described
functions appear to mediate the conservation of intracellular
GSH in situations where is most needed. Ophthalmate
appears to be a marker of early tumor development and
growth in animals with chronic viral hepatitis.
Factors such as diet, lifestyle, chemical carcinogens and
chronic inﬂammation may result in cellular oxidative stress
and it has been shown that reactive oxygen species play a
key role in the progression of liver disease. The main sources
of hepatic reactive oxygen species are the mitochondria,
cytochrome p450, endotoxin-activated macrophages (Kupf-
fer cells), and neutrophils [29], and this has been observed
to increase in patients with chronic viral hepatitis, alcoholic
hepatitis, and nonalcoholic fatty liver disease [29–31]. Since
the glutathione redox state of a patient can change relatively
fast, serial plasma measurements of the glutathione system
and their analog ophthalmate could prove to be beneﬁcial in
theevaluationofpatients withliverdisease and potentially as
a biomarker of HCC.
Previous PET scan imaging studies in our institution
have shown that some animals with early-stage HCC (well-
diﬀerentiated) are not FDG avid, and diﬀerences in FDG
uptake between HCC and the surrounding hepatic tissues
may not be evident. However, both acetate and choline
were picked up by this well-diﬀerentiated HCC (Figure 1(a))
due to diﬀerent tracer metabolism between HCC and its
surrounding liver tissues [12, 32]. After tumor ablation,
lower accessibility of the tracer to the ablated region might
contribute to the lower uptake as the microvasculatures
might be sealed oﬀ by the heat (Figure 1(b)) in addition to
the ceased metabolism of necrotic tumor cells as result of the
thermal injury.
Although the WHV model for HCC is a reliable model,
it has limitations. Animals develop chronic viral hepatitis
resembling the one in the human but limited bridging portal
ﬁbrosis with limited portal hypertension. The sample size
in the experimental group was limited by the availability of
animals, and during the protocol, one animal was excluded
due to sickness. Livers had multiple tumors of diﬀerent
sizes, but the correlation of tumor volume with glutathione
disturbances and OA concentration was beyond the scope of
our present study. Moreover, the redox state of an animal can
also be inﬂuenced by food intake and genetic factors. In spite
of these limitations, our ﬁndings resemble those seen in our
previous work on the VX2 rabbit model of secondary liver
tumors [11] and of others in humans [33].
5. Conclusion
Disturbances of the glutathione redox buﬀer system and
higher concentrations of ophthalmate were found in this
animal model of woodchuck hepatitis virus-induced HCC.
The role of these compounds as biomarkers of early tumor
development in patients with end-stage liver disease remains
to be determined.
Abbreviations
HCC: Hepatocellular carcinoma
HBV: Hepatitis B virus
HCV: Hepatitis C virus
WHV: Woodchuck hepatitis virus
GSH: Reduced glutathione
GSSG: Glutathione disulﬁde
OA: Ophthalmate
RFA: Radiofrequency ablation
RBC: Red blood cell
IAA: Iodoacetate
PET: Positron emission tomography
FDG: 2-deoxy-2[18F]ﬂuoro-D-glucose
LC-MS: Liquid chromatography-mass
spectrometry
3H: Tritium
NNAL-O-glucuronide: 4-[(methylnitrosamino)-1-(3-
pyridyl)-but-1-yl]-b-O-D-
glucosiduronic
acid
MRP1: Multidrug resistance protein 1
ROS: Reactive oxygen species.
Disclosure
This work was presented in part at the International Liver
Cancer Association (ILCA), Chicago, 2008, the International
LiverTransplantSociety(ILTS),Paris,2008,andatthejoined
meetingoftheInternationalandAmericasHepatoPancreato
Biliary Associations (IHPBA and AHPBA), Buenos Aires,
2010.
Acknowledgments
This work was supported by the RoadMap NIH grant
initiative of NIDDK 5R33DK070291, 1R01ES013925, and a
V a l l e y l a bg r a n t .R .A .I b a r r aw a ss u p p o r t e db yaR u t hL .
Kirschstein National Research Service Award NIH/NIDDK
(T32-DK007319). Special thanks to James M. Anderson
M.D., Ph.D., Department of Pathology. This work was
supported by Roadmap NIH Grant no. 5R33DK070291,
1R01ES013925, and a Valleylab grant.
References
[1] H.B.El-Serag,“Hepatocellularcarcinoma:recenttrendsinthe
United States,” Gastroenterology, vol. 127, no. 5, 1, pp. S27–
S34, 2004.
[2] M. Fuss and C. R. Thomas Jr., “Stereotactic body radiation
therapy: an ablative treatment option for primary and sec-
ondary liver tumors,” Annals of Surgical Oncology, vol. 11, no.
2, pp. 130–138, 2004.8 HPB Surgery
[3] J. Bruix and M. Sherman, “Management of hepatocellular
carcinoma,” Hepatology, vol. 42, no. 5, pp. 1208–1236, 2005.
[4] J. Bruix and M. Sherman, “Management of hepatocellular
carcinoma: an update,” Hepatology, vol. 53, no. 3, pp. 1020–
1022, 2011.
[5] M. Sherman, “Screening for hepatocellular carcinoma,” Hepa-
tology Research, vol. 37, supplement 2, pp. S152–S165, 2007.
[6] P.Stefaniuk,J.Cianciara,andA.Wiercinska-Drapalo,“Present
and future possibilities for early diagnosis of hepatocellular
carcinoma,” World Journal of Gastroenterology, vol. 16, no. 4,
pp. 418–424, 2010.
[7] L. Lusini, S. A. Tripodi, R. Rossi et al., “Altered glutathione
anti-oxidant metabolism during tumor progression in human
renal-cell carcinoma,” International Journal of Cancer, vol. 91,
no. 1, pp. 55–59, 2001.
[ 8 ]J .N a v a r r o ,E .O b r a d o r ,J .C a r r e t e r oe ta l . ,“ C h a n g e si n
glutathione status and the antioxidant system in blood and
in cancer cells associate with tumour growth in vivo,” Free
Radical Biology and Medicine, vol. 26, no. 3-4, pp. 410–415,
1999.
[9] P. Jaruga, T. H. Zastawny, J. Skokowski, M. Dizdaroglu, and
R. Olinski, “Oxidative DNA base damage and antioxidant
enzyme activities in human lung cancer,” FEBS Letters, vol.
341, no. 1, pp. 59–64, 1994.
[ 1 0 ]T .S o g a ,R .B a r a n ,M .S u e m a t s ue ta l . ,“ D i ﬀerential metabo-
lomics reveals ophthalmic acid as an oxidative stress bio-
marker indicating hepatic glutathione consumption,” Journal
of Biological Chemistry, vol. 281, no. 24, pp. 16768–16776,
2006.
[11] R. Abbas, R. S. Kombu, R. A. Ibarra, K. K. Goyal, H. Brunen-
graber, and J. R. Sanabria, “The dynamics of glutathione
species and ophthalmate concentrations in plasma from the
VX2 rabbit model of secondary liver tumors,” HPB Surgery,
vol. 2011, Article ID 709052, 8 pages, 2011.
[12] N. Salem, Y. Kuang, D. Corn et al., “[(Methyl)1-11C]-acetate
metabolism in hepatocellular carcinoma,” Molecular Imaging
and Biology, vol. 13, no. 1, pp. 140–151, 2011.
[13] F. Wang, Y. Kuang, N. Salem, P. W. Anderson, and Z. Lee,
“Cross-species hybridization of woodchuck hepatitis viral
infection-induced woodchuck hepatocellular carcinoma using
human, rat and mouse oligonucleotide microarrays,” Journal
ofGastroenterologyandHepatology,vol.24,no.4,pp.605–617,
2009.
[ 1 4 ]J .S u m m e r s ,J .M .S m o l e c ,a n dR .S n y d e r ,“ Av i r u ss i m i l a rt o
human hepatitis B virus associated with hepatitis and hep-
atoma in woodchucks,” Proceedings of the National Academy
of Sciences of the United States of America,v o l .7 5 ,n o .9 ,p p .
4533–4537, 1978.
[15] J. L. Gerin, P. J. Cote, B. E. Korba, and B. C. Tennant,
“Hepadnavirus-induced liver cancer in woodchucks,” Cancer
Detection and Prevention, vol. 14, no. 2, pp. 227–229, 1989.
[16] R. S. Kombu, G. F. Zhang, R. Abbas et al., “Dynamics of
glutathione and ophthalmate traced with 2H-enriched body
water in rats and humans,” American Journal of Physiology—
Endocrinology and Metabolism, vol. 297, no. 1, pp. E260–E269,
2009.
[17] N. Salem, Y. Kuang, F. Wang, G. T. Maclennan, and Z. Lee,
“PET imaging of hepatocellular carcinoma with 2-deoxy-
2[18F] ﬂuoro-D-glucose, 6-deoxy-6[18F]ﬂuoro-D-glucose,
[1−11C]-acetate and [N-methyl-11C]-choline,” Quarterly
Journal of Nuclear Medicine and Molecular Imaging, vol. 53,
no. 2, pp. 144–156, 2009.
[18] G. Mantovani, C. Madeddu, A. Maccio et al., “Cancer-
related anorexia/cachexia syndrome and oxidative stress:
an innovative approach beyond current treatment,” Cancer
Epidemiology, Biomarkers & Prevention, vol. 13, no. 10, pp.
1651–1659, 2004.
[19] G. Mantovani, A. Maccio, C. Madeddu et al., “Quantitative
evaluation of oxidative stress, chronic inﬂammatory indices
and leptin in cancer patients: correlation with stage and
performance status,” International Journal of Cancer, vol. 98,
no. 1, pp. 84–91, 2002.
[20] R. Franco and J. A. Cidlowski, “Apoptosis and glutathione:
beyond an antioxidant,” Cell Death & Diﬀerentiation, vol. 16,
no. 10, pp. 1303–1314, 2009.
[21] J. M. Estrela, A. Ortega, and E. Obrador, “Glutathione in
cancer biology and therapy,” Critical Reviews in Clinical
Laboratory Sciences, vol. 43, no. 2, pp. 143–181, 2006.
[22] H. H. Wu and J. Momand, “Pyrrolidine dithiocarbamate
prevents p53 activation and promotes p53 cysteine residue
oxidation,” Journal of Biological Chemistry, vol. 273, no. 30,
pp. 18898–18905, 1998.
[23] C. K. Sen and L. Packer, “Antioxidant and redox regulation
of gene transcription,” FASEB Journal,v o l .1 0 ,n o .7 ,p p .
709–720, 1996.
[24] J. Carretero, E. Obrador, M. J. Anasagasti, J. J. Martin, F.
Vidal-Vanaclocha, and J. M. Estrela, “Growth-associated
changes in glutathione content correlate with liver metastatic
activity of B16 melanoma cells,” Clinical and Experimental
Metastasis, vol. 17, no. 7, pp. 567–574, 1999.
[25] M.E.Anderson,R.J.Bridges,andA.Meister,“Directevidence
for inter-organ transport of glutathione and that the non-
ﬁltration renal mechanism for glutathione utilization involves
γ-glutamyl transpeptidase,” Biochemical and Biophysical
Research Communications, vol. 96, no. 2, pp. 848–853,
1980.
[26] G. K. Balendiran, R. Dabur, and D. Fraser, “The role of
glutathione in cancer,” Cell Biochemistry and Function, vol. 22,
no. 6, pp. 343–352, 2004.
[ 2 7 ]E .M .L e s l i e ,K .I .I t o ,P .U p a d h y a y a ,S .S .H e c h t ,R .G .D e e l e y ,
a n dS .P .C o l e ,“ T r a n s p o r to ft h eβ-O-glucuronide conjugate
of the tobacco-speciﬁc carcinogen 4-(methylnitrosamino)-1-
(3-pyridyl)-1-butanol (NNAL) by the multidrug resistance
protein 1 (MRP1). Requirement for glutathione or a non-
sulfur-containing analog,” Journal of Biological Chemistry, vol.
276, no. 30, pp. 27846–27854, 2001.
[28] N. Ballatori and W. J. Dutczak, “Identiﬁcation and character-
ization of high and low aﬃnity transport systems for reduced
glutathione in liver cell canalicular membranes,” Journal of
Biological Chemistry, vol. 269, no. 31, pp. 19731–19737, 1994.
[29] C. Loguercio and A. Federico, “Oxidative stress in viral and
alcoholic hepatitis,” Free Radical Biology & Medicine, vol. 34,
no. 1, pp. 1–10, 2003.
[30] S. Abel, K. M. De, D. J. van Schalkwyk, S. Swanevelder,
M. C. Kew, and W. C. Gelderblom, “Altered lipid proﬁle,
oxidative status and hepatitis B virus interactions in human
hepatocellular carcinoma,” Prostaglandins, Leukotrienes
&E s s e n t i a lF a t t yA c i d s , vol. 81, no. 5-6, pp. 391–399,
2009.
[31] S. Seki, T. Kitada, T. Yamada, H. Sakaguchi, K. Nakatani,
and K. Wakasa, “In situ detection of lipid peroxidation and
oxidative DNA damage in non-alcoholic fatty liver diseases,”
Journal of Hepatology, vol. 37, no. 1, pp. 56–62, 2002.HPB Surgery 9
[32] Y. Kuang, N. Salem, H. Tian et al., “Imaging lipid synthesis
in hepatocellular carcinoma with [methyl-11C]choline:
correlation with in Vivo metabolic studies,” Journal of Nuclear
Medicine, vol. 52, no. 1, pp. 98–106, 2011.
[33] K. T. Lee, S. M. Tsai, S. N. Wang et al., “Glutathione status
in the blood and tissues of patients with virus-originated
hepatocellular carcinoma,” Clinical Biochemistry, vol. 40, no.
15, pp. 1157–1162, 2007.